167 related articles for article (PubMed ID: 32020720)
1. Prognostic value of serum soluble interleukin-23 receptor and related T-helper 17 cell cytokines in non-small cell lung carcinoma.
Liu D; Xing S; Wang W; Huang X; Lin H; Chen Y; Lan K; Chen L; Luo F; Qin S; Liang R; Bai C; Xu J; Liu W
Cancer Sci; 2020 Apr; 111(4):1093-1102. PubMed ID: 32020720
[TBL] [Abstract][Full Text] [Related]
2. IL-23/IL-17 axis and soluble receptors isoforms sIL-23R and sIL-17RA in patients with rheumatoid arthritis-presenting periodontitis.
Rodríguez-Montaño R; Bernard-Medina AG; Oregon-Romero E; Martínez-Rodríguez VMDC; Pita-López ML; Gómez-Meda BC; Guerrero-Velázquez C
J Clin Lab Anal; 2021 Sep; 35(9):e23963. PubMed ID: 34403509
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.
Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE
Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-27 receptor alpha is a valuable prognostic biomarker for acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Liu S; Han J; Gong H; Li Y; Bao X; Qi J; Liu H; Chen J; Wu X; Xu Y; Ma S; Wu D
Sci Rep; 2018 Jul; 8(1):10328. PubMed ID: 29985424
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer.
Xu C; Hao K; Yu L; Zhang X
Biomarkers; 2014 Jun; 19(4):287-90. PubMed ID: 24731052
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
[TBL] [Abstract][Full Text] [Related]
10. Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer.
De Vita F; Turitto G; di Grazia M; Frattolillo A; Catalano G
Tumori; 1998; 84(1):33-8. PubMed ID: 9619711
[TBL] [Abstract][Full Text] [Related]
11. Association between Th17-related cytokines and risk of non-small cell lung cancer among patients with or without chronic obstructive pulmonary disease.
Liao C; Yu ZB; Meng G; Wang L; Liu QY; Chen LT; Feng SS; Tu HB; Li YF; Bai L
Cancer; 2015 Sep; 121 Suppl 17():3122-9. PubMed ID: 26331819
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation in IL-6 receptors is associated with upregulated IL-17A related signaling in CD4+ T cells of children with autism.
Nadeem A; Ahmad SF; Attia SM; Al-Ayadhi LY; Al-Harbi NO; Bakheet SA
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109783. PubMed ID: 31655158
[TBL] [Abstract][Full Text] [Related]
13. Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer.
Duan MC; Han W; Jin PW; Wei YP; Wei Q; Zhang LM; Li JC
Inflammation; 2015 Dec; 38(6):2156-65. PubMed ID: 26077695
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumors.
Orditura M; De Vita F; Roscigno A; Auriemma A; Infusino S; Catalano G
Int J Mol Med; 1998 Jul; 2(1):75-9. PubMed ID: 9854147
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in patients with stage III and IV non-small cell lung cancer].
Song LH; Song XR; Liu MQ; Zhang XQ; Zheng L; Li XJ; Liu PX
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):345-8. PubMed ID: 15312344
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.
Miralles M; Eixarch H; Tejero M; Costa C; Hirota K; Castaño AR; Puig M; Stockinger G; Montalban X; Bosch A; Espejo C; Chillon M
Neurotherapeutics; 2017 Oct; 14(4):1095-1106. PubMed ID: 28593439
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
18. Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib.
Kanazawa S; Yamaguchi K; Kinoshita Y; Komiyama Y; Muramatsu M; Nomura S
J Cancer Res Clin Oncol; 2006 Nov; 132(11):719-25. PubMed ID: 16835747
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer.
Gu X; Tian T; Zhang B; Liu Y; Yuan C; Shao L; Guo Y; Fan K
Tumour Biol; 2015 Apr; 36(4):2651-6. PubMed ID: 25480413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]